Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

Chung Feng Huang; Manar Hijaze Awad; Meital Gal-Tanamy; Ming Lung Yu

doi:https://doi.org/10.3350/CMH.2024.0472

Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

Chung Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming Lung Yu

Bar-Ilan University - Azrieli Faculty of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1023-1025
Number of pages	3
Journal	Clinical and molecular hepatology
Volume	30
Issue number	4
DOIs	https://doi.org/10.3350/CMH.2024.0472
State	Published - Oct 2024

Keywords

DAA
HCV
SVR

All Science Journal Classification (ASJC) codes

Molecular Biology
Hepatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://doi.org/10.3350/CMH.2024.0472

Cite this

Huang, C. F., Awad, M. H., Gal-Tanamy, M., & Yu, M. L. (2024). Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”. Clinical and molecular hepatology, 30(4), 1023-1025. https://doi.org/10.3350/CMH.2024.0472

Huang, Chung Feng ; Awad, Manar Hijaze ; Gal-Tanamy, Meital et al. / Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era : Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”. In: Clinical and molecular hepatology. 2024 ; Vol. 30, No. 4. pp. 1023-1025.

@article{79b1c3373574494e8b3d13ebaeb7df41,

title = "Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”",

keywords = "DAA, HCV, SVR",

author = "Huang, {Chung Feng} and Awad, {Manar Hijaze} and Meital Gal-Tanamy and Yu, {Ming Lung}",

year = "2024",

month = oct,

doi = "https://doi.org/10.3350/CMH.2024.0472",

language = "الإنجليزيّة",

volume = "30",

pages = "1023--1025",

journal = "Clinical and molecular hepatology",

issn = "2287-2728",

publisher = "Korean Association for the Study of the Liver",

number = "4",

}

Huang, CF, Awad, MH, Gal-Tanamy, M & Yu, ML 2024, 'Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”', Clinical and molecular hepatology, vol. 30, no. 4, pp. 1023-1025. https://doi.org/10.3350/CMH.2024.0472

Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”. / Huang, Chung Feng; Awad, Manar Hijaze; Gal-Tanamy, Meital et al.
In: Clinical and molecular hepatology, Vol. 30, No. 4, 10.2024, p. 1023-1025.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era

T2 - Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

AU - Huang, Chung Feng

AU - Awad, Manar Hijaze

AU - Gal-Tanamy, Meital

AU - Yu, Ming Lung

PY - 2024/10

Y1 - 2024/10

KW - DAA

KW - HCV

KW - SVR

UR - http://www.scopus.com/inward/record.url?scp=85208615909&partnerID=8YFLogxK

U2 - https://doi.org/10.3350/CMH.2024.0472

DO - https://doi.org/10.3350/CMH.2024.0472

M3 - رسالة

C2 - 38946463

SN - 2287-2728

VL - 30

SP - 1023

EP - 1025

JO - Clinical and molecular hepatology

JF - Clinical and molecular hepatology

IS - 4

ER -

Huang CF, Awad MH, Gal-Tanamy M, Yu ML. Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”. Clinical and molecular hepatology. 2024 Oct;30(4):1023-1025. doi: https://doi.org/10.3350/CMH.2024.0472

Keywords

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this